Want to see CABA full AI Analyst Report?
Total Valuation
Cabaletta Bio has a market cap or net worth of $495.69M. The enterprise value is $372.89M.
Market Cap$495.69M
Enterprise Value$372.89M
Share Statistics
Cabaletta Bio has 163,054,800 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding163,054,800
Owned by Insiders1.04%
Owned by Institutions32.55%
Financial Efficiency
Cabaletta Bio’s return on equity (ROE) is -1.50 and return on invested capital (ROIC) is -123.78%.
Return on Equity (ROE)-1.50
Return on Assets (ROA)-1.02
Return on Invested Capital (ROIC)-123.78%
Return on Capital Employed (ROCE)-1.50
Revenue Per Employee0.00
Profits Per Employee-1.04M
Employee Count161
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Cabaletta Bio is ―. Cabaletta Bio’s PEG ratio is 0.04.
PE Ratio―
PS Ratio0.00
PB Ratio2.00
Price to Fair Value2.00
Price to FCF-1.69
Price to Operating Cash Flow-2.38
PEG Ratio0.04
Income Statement
In the last 12 months, Cabaletta Bio had revenue of 0.00 and earned -167.86M in profits. Earnings per share was -1.64.
Revenue0.00
Gross Profit0.00
Operating Income-172.24M
Pretax Income-167.86M
Net Income-167.86M
EBITDA-164.21M
Earnings Per Share (EPS)-1.64
Cash Flow
In the last 12 months, operating cash flow was -142.84M and capital expenditures -444.00K, giving a free cash flow of -143.28M billion.
Operating Cash Flow-142.84M
Free Cash Flow-143.28M
Free Cash Flow per Share-0.88
Dividends & Yields
Cabaletta Bio pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta4.11
52-Week Price Change100.00%
50-Day Moving Average3.33
200-Day Moving Average2.79
Relative Strength Index (RSI)44.20
Average Volume (3m)4.25M
Important Dates
Cabaletta Bio upcoming earnings date is Aug 6, 2026, Before Open (Confirmed).
Last Earnings DateMay 14, 2026
Next Earnings DateAug 6, 2026
Ex-Dividend Date―
Financial Position
Cabaletta Bio as a current ratio of 2.77, with Debt / Equity ratio of 25.60%
Current Ratio2.77
Quick Ratio2.77
Debt to Market Cap0.01
Net Debt to EBITDA0.34
Interest Coverage Ratio-85.95
Taxes
In the past 12 months, Cabaletta Bio has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Cabaletta Bio EV to EBITDA ratio is -1.02, with an EV/FCF ratio of -1.27.
EV to Sales0.00
EV to EBITDA-1.02
EV to Free Cash Flow-1.27
EV to Operating Cash Flow-1.28
Balance Sheet
Cabaletta Bio has $116.64M in cash and marketable securities with $26.45M in debt, giving a net cash position of $90.19M billion.
Cash & Marketable Securities$116.64M
Total Debt$26.45M
Net Cash$90.19M
Net Cash Per Share$0.55
Tangible Book Value Per Share$1.10
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Cabaletta Bio is $15.75, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$15.75
Price Target Upside357.85% Upside
Analyst ConsensusStrong Buy
Analyst Count7
Revenue Growth Forecast―
EPS Growth Forecast22.16%